Skip to main content

Eli Lilly and Company(LLY-N)
NYSE

868.88 USD
Today's Change-9.43decrease-1.07%decrease
Real-Time Last Update 02/10/25Last Sale Cboe BZX Real-Time

Eli Lilly and Company

LILLY CORPORATE CENTER
INDIANAPOLIS IN 46285 USA
P: 317-276-2000
http://www.lilly.com

Profile

Eli Lilly and Company, one of the world's largest pharmaceutical companies, boasts a diversified product profile including a solid lineup of new successful drugs. It also has a dependable pipeline as it navigates through challenges like patent expirations of several drugs and rising pricing pressure on its U.S. diabetes franchise. Its pharmaceutical product categories are neuroscience, diabetes, oncology, immunology and others. Over the past few years, Lilly has been actively seeking acquisitions and in-licensing deals to boost its product portfolio and pipeline. The purchase of ImClone Systems brought with it cancer compound, Erbitux. The acquisition of ICOS Corporation gave Lilly full control over erectile dysfunction drug, Cialis. Its other acquisitions include Hypnion, Inc., CoLucid Pharmaceuticals added Reyvow for acute migraine, Loxo Oncology and Dermira. Lilly has collaboration agreements with several companies including Incyte, Boehringer Ingelheim and Innovent Biologics among others.

Key Executives

NameTitle
Information not available.

More from The Globe